Rational combinations of immunotherapy with radiotherapy in ovarian cancer

FG Herrera, M Irving, LE Kandalaft, G Coukos - The Lancet Oncology, 2019 - thelancet.com
Except for its use in palliative care, radiotherapy has been largely abandoned in the
management of ovarian cancer because of the recognised efficacy and lower toxicity of …

Who are the long-term survivors of high grade serous ovarian cancer?

C Hoppenot, MA Eckert, SM Tienda, E Lengyel - Gynecologic oncology, 2018 - Elsevier
Although the median survival for epithelial ovarian cancer (EOC) is< 5 years, approximately
15% of patients will survive for> 10 years. A better understanding of these exceptional …

Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells

Y Han, B Kim, U Cho, IS Park, SI Kim… - Oncogene, 2019 - nature.com
Mitochondria undergo fission and fusion continually for survival through the course of
cellular adaption processes in response to changes in the surrounding environment …

LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer

H Yan, H Li, MA Silva, Y Guan, L Yang, L Zhu… - Journal of Experimental …, 2019 - Springer
Abstract Background Long noncoding RNAs (lncRNAs) have been reported to be
associated with the proliferation of several cancer cells. The aim of this study was to …

Wise management of ovarian cancer: on the cutting edge

S Boussios, C Mikropoulos, E Samartzis… - Journal of personalized …, 2020 - mdpi.com
Epithelial ovarian cancer (EOC) is the fifth leading cause of cancer mortality among women.
Two-thirds of patients present at advanced stage at diagnosis, and the estimated 5 year …

Development of a multiplexed giant magnetoresistive biosensor array prototype to quantify ovarian cancer biomarkers

T Klein, W Wang, L Yu, K Wu, KLM Boylan… - Biosensors and …, 2019 - Elsevier
In this work, we developed benchtop and handheld Giant Magnetoresistive (GMR)
biosensing systems that serve as platforms for detecting a wide variety of protein biomarkers …

Characterization of ovarian cancer survival by histotype and stage: A nationwide study in Norway

RT Fortner, CB Trewin‐Nybråten… - … Journal of Cancer, 2023 - Wiley Online Library
Contemporary population‐based data on ovarian cancer survival using current subtype
classifications and by surgical status are sparse. We evaluated 1‐, 3‐, 5‐and 7‐year relative …

Disparities in ovarian cancer survival in the United States (2001‐2009): Findings from the CONCORD‐2 study

SL Stewart, R Harewood, M Matz, SH Rim… - Cancer, 2017 - Wiley Online Library
BACKGROUND Ovarian cancer is the fifth leading cause of cancer death among women in
the United States. This study reports ovarian cancer survival by state, race, and stage at …

Germline and somatic mutations of homologous recombination-associated genes in Japanese ovarian cancer patients

K Sugino, R Tamura, H Nakaoka, N Yachida… - Scientific reports, 2019 - nature.com
We explored the frequency of germline and somatic mutations in homologous recombination
(HR)-associated genes in major histological types of ovarian cancer. We performed targeted …

[HTML][HTML] Plant-based diet indices and their interaction with ambient air pollution on the ovarian cancer survival: A prospective cohort study

F Cao, R Wang, L Wang, YZ Li, YF Wei, G Zheng… - Ecotoxicology and …, 2024 - Elsevier
Background Ambient air pollution might serve as a prognostic factor for ovarian cancer (OC)
survival, yet the relationships between plant-based diet indices (PDIs) and OC survival …